Clinical Trial Detail

NCT ID NCT02840409
Title Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors The Hospital for Sick Children
Indications

malignant glioma

Therapies

Vinblastine

Bevacizumab + Vinblastine

Age Groups: adult child

No variant requirements are available.